Transcription of <800> Hazardous Drugs—Handling in Healthcare Settings …
{{id}} {{{paragraph}}}
<800> Hazardous Drugs Handling in Healthcare SettingsType of Posting Revision Bulletin Posting Date 26 Jun 2020 Official Date 01 Jul 2020 Expert Committee Compounding Reason for Revision Compliance In accordance with the Rules and Procedures of the 2015 2020 Council of Experts, the Compounding Expert Committee (CMP EC) revised General Chapter <800> Hazardous Drugs Handling in Healthcare Settings to clarify that for the purposes of the chapter, the term antineoplastic is intended to refer to antineoplastic Hazardous drugs (HDs) included in Table 1 of the most current National Institute for Occupational Safety and Health (NIOSH) list.
Jun 26, 2020 · For the purposes of this chapter, the term antineoplastic only refers to antineoplastic drugs included in Table 1 of the most current NIOSH list. The revised text in <800> will become official on July 1, 2020. The 2016 NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings remains the most current list until NIOSH ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Of Antineoplastic and Other Hazardous, Centers for Disease Control and Prevention, Of Antineoplastic and Other Hazardous Drugs, CRUSH, Hazardous, Chemotherapy and Other Hazardous, Antineoplastic and Other hazardous, Sterile Compounding of Hazardous Drugs, And other hazardous, Of antineoplastic and other, Antineoplastic Drug Administration: Vesicant and, Antineoplastic